DarioHealth
NEW YORK, New York, United States · Biotechnology, Fitness, Health Care · 239 employees
DarioHealth Corp. (NASDAQ:DRIO) Dario is changing the way people manage their health, with consumer-friendly digital solutions proven to power lasting behavior change. Dario integrates comprehensive support across a wide range of common and connected health needs, from well-being to chronic condition management, to help our members find long-term success. Billions of data insights from a decade of
Funding history
- Funding Round — $17.5M — Oct 2025
- Funding Round — $32.5M — May 2025
- Funding Round — $18.8M — Jan 2025
- Funding Round — $6.8M — Jan 2025
- Funding Round — $22.4M — Feb 2024
Recent signals
- Nov 10, 2025: DarioHealth Corp. Amends Credit Agreement
- Nov 05, 2025: SEC 8-K (1.01): On November 5, 2025, DarioHealth Corp. entered into a Credit Agreement Amendment with Callodine Commercial Finance, LLC and other financial institutions. This amendment includes a reset of financial covenants and waives financial-covenant testing for the second and third quarters of 2025. Additionally, it replaces the existing minimum cash covenant, introducing a requirement for a minimum of $10,000,000 in consolidated unencumbered liquid assets. A monthly reporting requirement for 13-week cash flows is established when liquidity falls below $11,000,000, with certain exceptions related to EBITDA. These adjustments are designed to enhance the company's liquidity management amid financial challenges.
- Oct 07, 2025: Raised $17.5M
- May 01, 2025: Raised $32.5M
- Apr 21, 2025: DarioHealth Appoints Chen Franco-Yehuda as Chief Financial Officer
- Mar 07, 2025: DarioHealth Expands Behavioral Health Offerings Through Partnership with Rula Health
- Feb 06, 2025: Launched DarioHealth Expands Health Plan Client Base with New Blue Cross Blue Shield Agreement
- Jan 17, 2025: Raised $18.8M
See plans & pricing → Track DarioHealth’s funding, hiring, and signals — with verified contacts — on Fundz.